KENYON LAWRENCE A (CIK 1230484) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-14). Recent activity: Buy OTLK (101,010 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | Outlook Therapeutics, Inc. (OTLK) | Chief Financial Officer | Buy | 101,010 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-08-14